U.S. Markets open in 5 hrs 12 mins

Rafael Holdings, Inc. (RFL)

NYSE - NYSE Delayed Price. Currency in USD
Add to watchlist
36.32-0.01 (-0.03%)
At close: 4:00PM EDT

Rafael Holdings, Inc.

520 Broad Street
Newark, NJ 07102
United States
212 658 1450

Full Time Employees54

Key Executives

NameTitlePayExercisedYear Born
Mr. Howard S. JonasFounder & Chairman250kN/A1956
Mr. Menachem AshPres & Gen. Counsel350.08kN/A1972
Mr. David A. PolinskyChief Financial Officer276.5kN/A1972
Dr. Ameet MallikCEO & DirectorN/AN/AN/A
Mr. William ConklingChief Commercial OfficerN/AN/AN/A
Ms. Joyce J. Mason Esq.Corp. Sec.N/AN/A1959
Amounts are as of December 31, 2020 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.


Rafael Holdings, Inc. owns commercial real estate assets and interests in pre-clinical and clinical stage pharmaceutical companies. The company operates in two segments, Pharmaceuticals and Real Estate. It engages in the leasing of a commercial office building, as well as an associated 800-car public garage; and development and commercialization of therapies that exploit the metabolic differences between normal cells and cancer cells. Rafael Holdings, Inc. is headquartered in Newark, New Jersey.

Corporate Governance

Rafael Holdings, Inc.’s ISS Governance QualityScore as of June 1, 2021 is 9. The pillar scores are Audit: 8; Board: 9; Shareholder Rights: 9; Compensation: 8.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.